Gene · 23049
Papers2,633
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,633
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The transcription factor C/EBPβ promotes hyperglycemia-elicited glycolysis and liver cancer progression. | Nat Commun | 2026 | 42722647 | PubTator, text mining | PubMed |
| Integrated LiP-MS and quantitative proteomics reveal coordinated alterations in protein conformation and expression across tumor and peritumoral regions in hepatocellular carcinoma. | Sci Rep | 2026 | 42686792 | PubTator, text mining | PubMed |
| Degradation of a graphene-reinforced polyamide by fungi: When culture conditions matter. | J Environ Sci (China) | 2026 | 42680386 | PubTator, text mining | PubMed |
| Cell cycle-dependent translation-mediated turnover of the long noncoding RNA Malat1. | J Cell Biol | 2026 | 42640252 | PubTator, text mining | PubMed |
| Functional phosphoproteomic analysis of SMG1 in nonsense-mediated mRNA decay and DNA damage repair in cancer. | Front Syst Biol | 2026 | 42630458 | PubTator, text mining | PubMed |
| Targeting a novel metabolic vulnerability of non-small cell lung cancer to fatty acid oxidation surmounts chemoresistance. | Drug Resist Updat | 2026 | 42556029 | PubTator, text mining | PubMed |
| Global Framework for Lip Product Safety: A Review of the Regulatory Blind Spot in the Modern Market. | Integr Environ Assess Manag | 2026 | 42552978 | PubTator, text mining | PubMed |
| Induction and propagation of ferroptosis evasion by FTH1P7 drives sorafenib resistance in hepatocellular carcinoma. | Eur J Pharmacol | 2026 | 42546831 | PubTator, text mining | PubMed |
| Two stress-responsive kinases suppress ferroptosis by activating antioxidant programs under mild oxidative stress. | Signal Transduct Target Ther | 2026 | 42543384 | PubTator, text mining | PubMed |
| SMG1 in hepatocellular carcinoma: A context-dependent tumor suppressor and a targetable node for NMD-directed immunotherapy. | Crit Rev Oncol Hematol | 2026 | 42537828 | PubTator, text mining | PubMed |
| Balancing Beats and Bleeding: The Evolving Landscape of Atrial Fibrillation and Anticoagulation in the Past Two Decades. | Clin Appl Thromb Hemost | 2026 | 42460738 | PubTator, text mining | PubMed |
| EIF4A3-dependent nonsense-mediated decay buffers AML1-ETO9a dosage and modulates outcome in t(8;21) acute myeloid leukemia. | Leukemia | 2026 | 42448936 | PubTator, text mining | PubMed |
| Microbial Contamination, Degradation Characteristics of Dominant Bacteria on the Hull of the Nanhai No. 1 Shipwreck. | Int J Mol Sci | 2026 | 42353346 | PubTator, text mining | PubMed |
| Hypoxia-induced lnc-IRP drives oxaliplatin resistance in colorectal cancer through IRP2 sequestration and iron metabolism reprogramming. | J Transl Med | 2026 | 42332736 | PubTator, text mining | PubMed |
| Lip reading systems for Urdu alphabets in diverse environments. | Sci Rep | 2026 | 42289468 | PubTator, text mining | PubMed |
| Investigating the Impact of Curcumin on the Methylation of DNMT1, CDH1, SMG1, and WT1 Genes in the MIAPaCa2 Cell Line Using High-Resolution Melting Analysis Compared to Methylation-Specific PCR. | Asian Pac J Cancer Prev | 2026 | 42169570 | PubTator, text mining | PubMed |
| Resveratrol inhibits aerobic glycolysis and promotes cuproptosis in acute myeloid leukemia via the PI3K/AKT signaling pathway. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 42056286 | PubTator, text mining | PubMed |
| Genes Involved in Lipid, Carbohydrate, and Protein Metabolism as Candidates Affecting Beef Flavor. | Animals (Basel) | 2026 | 41975982 | PubTator, text mining | PubMed |
| Nonsense-mediated mRNA decay inhibition reshapes the cancer immunopeptidome. | Immunity | 2026 | 41956098 | PubTator, text mining | PubMed |
| Nonsense-Mediated RNA Decay Is a Targetable Vulnerability in Splicing Factor Mutant Myeloid Neoplasms by Enhancing R-Loop Accumulation and DNA Damage. | Cancer Res | 2026 | 41954618 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23049/papers